AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
Ischemic Heart Disease (IHD) Drugs Strategic Research Report 2024: Market to Grow by $1.1 Billion During 2023-2030, Driven by Increasing Demand for Combination Therapies [Yahoo! Finance]
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks [Yahoo! Finance]
Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Conver
Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now? [Yahoo! Finance]